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DOI: 10.1039/c1an15167cThe differentiation of stem cells into multi-lineages is essential to aid the development of tissue
engineered materials that replicate the functionality of their tissue of origin. For this study, Raman
spectroscopy was used to monitor the formation of a bone-like apatite mineral during the
differentiation of human mesenchymal stem cells (hMSCs) towards an osteogenic lineage. Raman
spectroscopy observed dramatic changes in the region dominated by the stretching of phosphate groups
(950–970 cm1) during the period of 7–28 days. Changes were also seen at 1030 cm1 and 1070 cm1,
which are associated with the P–O symmetric stretch of PO4
3 and the C–O vibration in the plane
stretch of CO3
2. Multivariate factor analysis revealed the presence of various mineral species
throughout the 28 day culture period. Bone mineral formation was observed first at day 14 and was
identified as a crystalline, non-substituted apatite. During the later stages of culture, different mineral
species were observed, namely an amorphous apatite and a carbonate, substituted apatite, all of which
are known to be Raman markers for a bone-like material. Band area ratios revealed that both the
carbonate-to-phosphate and mineral-to-matrix ratios increased with age. When taken together, these
findings suggest that the osteogenic differentiation of hMSCs at early stages resembles endochondral
ossification. Due to the various mineral species observed, namely a disordered amorphous apatite, a B-
type carbonate-substituted apatite and a crystalline non-substituted hydroxyapatite, it is suggested that
the bone-like mineral observed here can be compared to native bone. This work demonstrates the
successful application of Raman spectroscopy combined with biological and multivariate analyses for
monitoring the various mineral species, degree of mineralisation and the crystallinity of hMSCs as they
differentiate into osteoblasts.Introduction
The severity of disease and injury can impact upon the body’s
ability to self-heal resulting in the need for clinical intervention in
order to maintain tissue function. One aim of regenerative
medicine is to meet these needs with the production of functional
tissue engineered bone material, which would be used in several
applications where the loss of bone mass as a result of injury,
disease or age presents a significant problem.1 Central to this is
the re-establishment of tissue functionality by way of tissue-
specific cells, such as human bone marrow derived stem cells. The
success of a tissue engineered material is invariably dependent onaNanotechnology and Integrated Bioengineering Centre (NIBEC),
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This journal is ª The Royal Society of Chemistry 2011the ability of the cells to replicate the functionality of their tissue
of origin.
It is often difficult to expand sufficient numbers of tissue-
specific cells for use in regenerative medicine applications. Owing
to their ability for self-renewal and multi-lineage differentiation,
hMSCs have attracted widespread interest for their use in bone
tissue engineering applications, and more specifically for their
expansion and osteogenic differentiation potential in vitro.
hMSCs have the ability to differentiate into a number of cells
including osteoblasts, chondrocytes and adipocytes which then
allow the formation of bone, cartilage and adipose tissue.2–6
With over two million replacement procedures carried out
annually, bone is an ideal target for regenerative medicine ther-
apies. Bone tissue is a complex material which is formed from an
abundant intracellular matrix composed of organic proteins and
inorganic mineral salts. It consists of a carbonated hydroxyap-
atite-like mineral supported on a hydrated, collagen-rich protein
matrix. During fetal development of the mammalian skeletal
system there are two essential processes resulting in the creation
of new bone tissue, which are endochondral ossification andAnalyst, 2011, 136, 2471–2481 | 2471








3 v1 (P–O symmetric stretch)
1001–1003 Phenylalanine
1030 PO4
3 v3 (P–O asymmetric stretch)
1065–1070 CO3
2 v1 (P–O symmetric stretch)
1245, 1270 Amide III
1445 CH2 wag
1665 Amide Iintramembranous ossification. Intramembranous ossification is
the process by which flat bones such as those in the skull and
collarbones are formed from connective tissue. Endochondral
ossification occurs in the development of the long bones and
most of the other bones in the body, and involves the minerali-
sation of cartilaginous template.7,8
Bone formation is both a complex and tightly regulated
process that has been studied extensively. However, the
composition of the mineral and matrix environments during the
mineralisation process is not well understood.7,9 Researchers
generally use gene expression, microarray analysis, protein
expression and histological stains or any combination of
these.7–11 However, these methods fail to identify the composi-
tion of the mineral and matrix environments formed during
mineralisation, for example, alizarin red staining detects the
presence of mineral and the initial deposition of mineral but is
unable to characterise the mineral species. Raman spectroscopy
overcomes this limitation by using information from vibrations
of an ion or molecule within a mineral lattice, such as phosphate
and carbonate, to identify the mineral formed during osteogenic
differentiation, as well as the vibrations from the protein matrix.8
Indeed, the application of optical spectroscopy for stem cell
differentiation has been extensively reviewed.12 To date, the
study of the mineral and proteinaceous content in bone and also
the non-collagenous proteins found in the extracellular matrix
(ECM) has been dominated by the use of infrared spectros-
copy13–15 this is due to its sensitivity to the organic and inorganic
elements of bone tissue. Recently, Krafft et al. carried out studies
of hMSCs differentiating into osteoblasts,16 as have Salasznyk
et al.17 Krafft et al. used Fourier transform infrared spectroscopy
in order to identify the differentiation state of individual hMSCs.
Spectra from all samples highlighted bands which are charac-
teristic of proteins, including amide III, II and I (1250 cm1,
1540 cm1 and 1655 cm1), COO (1400 cm1) and CH3
(1455 cm1). Increases in the bands at 1025, 1080 and 1152 cm1
were also observed in the spectra of the control samples, these are
suggested to be due to the accumulation of glycogen. In the
spectra of the hMSCs that were cultured with osteogenic stim-
ulants there was evidence of increased bands at 987, 1086 and
1112 cm1, which are markers for a bone-like material, thus
indicating the presence of a mineral species.16 Furthermore,
various groups have highlighted the importance of phosphate
symmetric stretching during cell differentiation using infrared
spectroscopy.18–20
Despite this, the potential for in vivo applications is limited due
to the strong absorption of water. Moreover the spatial resolu-
tion for infrared is restricted to approximately 10 mm and
therefore infrared spectroscopy is not the preferred technique for
cell analysis. The low Raman scattering efficiency of water
combined with the high sensitivity and spatial resolution, and its
capability of obtaining spectra that are low in fluorescence using
near-infrared lasers place the Raman technique as the favorable
tool for cell analysis with a spatial resolution of between 0.1 and
1 mm. Also, the vibrational bands observed in Raman spectra
allow discrimination between the chemical species that are
present, and as such these bands are narrow so even small
changes in both frequency and band shape can be observed.
Raman spectroscopy is a measurement of the wavelength and
intensity of inelastically scattered light from a molecule and in2472 | Analyst, 2011, 136, 2471–2481biological tissues it is particularly sensitive to the vibrations of
the mineralised species, such as the carbonate and phosphate
bands found in bone tissue. This is due to the symmetrical
vibrations of a molecule which are the most intense bands
observed in Raman, and particularly in the Raman spectra of
mineralised tissue, the most prominent vibrational band is the
PO4
3 v1 symmetric stretch. Moreover, changes in both the
frequency and shape of the PO symmetric stretch are dependent
upon the mineral environment and will therefore change with
mineral crystallinity and ionic incorporation.7,10,21 There are
several bands to characterise the mineral and matrix in the
Raman spectrum of bone which are summarised in
Table 1.7–9,22,23
Using a combination of chemical, molecular and biological
characterisation techniques we investigated the bone nodules
formed from hMSCs. This paper presents evidence of a carbonated
apatite-like mineral formed in hMSCs at the earliest stages of
formationand its developmentover 28days.Weareable tomonitor
changes in thePO4
3 symmetrical band shape and frequency,which
reveal variations in crystallinity throughout the culture.Materials and methods
Cell culture
hMSCs derived from the bone marrow of a 22 year old female
(Lonza, UK) were used in this study. Cells were maintained in
non-osteogenic media: DMEM high glucose supplemented with
10% foetal bovine serum (Invitrogen, UK). hMSCs were directed
towards an osteogenic lineage by culturing hMSCs in non-oste-
ogenic media supplemented with 10 nM dexamethasone, 10 mM
b-glycerophosphate and 50 mM ascorbic acid-2-phosphate
(Sigma Aldrich, UK). hMSCs were seeded at a density of
approximately 1  105 cells per cm2 onto 15 mm  15 mm fused
silica substrates (The Technical Glass Company, UK). At 7 day
intervals cells were fixed in 100% methanol for 10 minutes,
samples were then air dried for 1 hour prior to Raman analysis.Alizarin red staining
To confirm and quantify the extent of mineralisation, alizarin red
staining (AR) was performed at days 7, 14, 21 and 28. Cells were
washed three times in PBS, fixed and permeabilised in 4% PFA
for 20 minutes at room temperature then washed twice in de-
ionised water to remove residual PFA. Cells were stained with
2% alizarin red for 30 minutes at room temperature with gentleThis journal is ª The Royal Society of Chemistry 2011
shaking. For the colorimetric assay 3.6% (0.1M) cetylpyridinium
chloride was added to each sample for 45 minutes and the optical
density was measured at 405 nm.
Raman spectroscopy
Confocal Raman spectra of non-osteogenic and osteogenic
cultured hMSC samples were obtained at seven day intervals up
to 28 days using the Renishaw inVIA Reflex spectrometer con-
nected to a Leica microscope and equipped with a 514 nm line-
focus laser and a lateral spatial resolution of 0.1 mm. Before the
acquisition of the Raman measurements the system was cali-
brated to the 520.5 cm1 spectral line using an internal silicon
reference. The laser beam was focused through a 50 (NA¼ 0.9)
long working distance (2 mm) objective. Under these conditions,
the laser spot size on the sample was 1.5 mm. Spectra covering the
fingerprint region (600–1800 cm1) were recorded at a resolution
of 1.7 cm1, with 200 s integration time per spectrum. Raman
backscattered radiation was collected by the same objective
passed through a 514 nm edge filter to block Rayleigh scattering
and reflected laser light, before being directed through a 50 mm
slit into the spectrometer equipped with a 1800 lines/mm grating,
and finally detected by a deep-depletion charge-coupled device
detector. Eight Raman spectra were acquired for each seven day
time point. The laser power (<10 mW) on the samples was
carefully controlled in order to avoid the damage or burning of
the samples.
Data pre-processing
It is accepted that spectral artifacts can have a considerable effect
on the interpretation of data. Therefore it is necessary to
distinguish between biochemical information and undesired
effects. With Raman spectroscopy, is it known that before data
interpretation can be performed, pre-processing of data should
be carried out. To this end Origin 7 software (OriginLab, USA)
was used to routinely pre-process the raw data. In the first
instance, band alignment was performed to correct for instru-
mental spectral shifts. As such all spectra were normalised using
the area of the 1449 cm1 band. A multipoint baseline correction
and smoothing by a 5-point Savitzky–Golay filter was also
employed for each Raman spectrum. Contributions of the fused
silica substrate were subtracted, however, small contributions
may still be present. The area of individual vibrational bands was
computed using the curve-fitting option of Origin 7 software.
Univariate analysis
The carbonate-to-phosphate ratios for each of the culture time
points were calculated from an average of three carbonate/
phosphate band intensities. Three spectra were chosen because
the intensity of the carbonate/phosphate band varied and there
was less mineral present in some spectra, thus the spectra chosen
had a strong mineral signal. The band intensity of the CO3
2 in
plane vibrations at 1070 cm1 was used as a measure of the
carbonate content. The intensity of the baseline corrected PO4
3
phosphate symmetric stretch at 960 cm1 was used as a metric of
the phosphate content. A global average was obtained from the
three averaged carbonate-to-phosphate ratios recorded for each
culture time point.This journal is ª The Royal Society of Chemistry 2011The intensity of the PO4
3 phosphate symmetric stretch dis-
cussed previously was used as the metric of mineral content for
the mineral-to-matrix ratio. The hydroxyproline peak at
850 cm1 was used as a measure of the matrix content. It is
noted that some researchers commonly use the amide I band
envelope at 1600 to 1720 cm1 as a measure of the matrix
content, however, this band can only be used when calculated
from the area. This is due to the variations observed in the
relative intensity of the 1665 cm1 and 1685 cm1 components
with cross-linking.21,24 Phenylalanine was also considered but
due to a contribution from non-collagenous matrix proteins it
could not be relied upon here to provide robust data with respect
to the matrix content. As with the carbonate-to-phosphate
ratios, the mineral-to-matrix ratios were calculated for each of
the culture time points from an average of three mineral/matrix
band intensities and a global average was obtained.7,8,10,21 Both
ratios were calculated from the intensity of the bands chosen,
because the intensity is less susceptible to background correction
errors than the area.Multivariate analysis
Principal component analysis (PCA) is a multivariate analysis
technique that is widely used to simplify a complex dataset of
multiple dimensions. It allows the reduction of a set of variables
into a smaller set of principal components that capture the
maximum variance in the data. This statistical method of anal-
ysis was preferred because it is able to resolve spectral compo-
nents that are present in different proportions. This is extremely
important when bone is the material being analysed, as it is
heterogeneous in nature, which results in considerable variations
in its spectra. The order of the principal components represents
their importance to the dataset, so the greatest variance is illus-
trated by the first principal component (PC1), the second greatest
variance is the second principal component (PC2) and so
forth.9,25,26 A scatter plot is generated from the data may show
groups of points representing variations within the dataset.Immunocytochemistry
After 14 and 28 days, cells were washed in large volumes of ice-
cold PBS (3  5 min) and fixed and permeabilised in 4% para-
formaldehyde containing 0.1% Triton X-100 for 20 minutes at 4
C and stained with bone specific proteins, including type-II
collagen (Sigma, UK), osteocalcin, osteopontin, alkaline phos-
phatase and SPARC (Santa Cruz Biotechnology Inc., USA).
Following washing, samples were treated with a blocking solu-
tion (PBS containing 1.0% BSA, 5% normal goat serum) for 30
minutes at room temperature. After blocking, the samples were
washed in PBS and then incubated with the appropriate primary
antibodies for 1 hour before exposure to the opposite secondary
antibodies. Following secondary antibody incubation, cells were
counterstained with DAPI nucleic acid stain (Molecular Probes,
Inc. Invitrogen). After washing twice in PBS, substrates were
mounted in Vectorshield mounting media (Vector Laboratories,
UK). The substrates were sealed using a clear nail varnish and
examined using a Carl Zeiss LSM5 Pascal (Carl Zeiss Micro-
Imaging, Germany) Confocal Laser Scanning Microscope
(CLSM). The diluent for all antibodies was PBS–1% BSA.Analyst, 2011, 136, 2471–2481 | 2473
Fig. 1 Phase contrast microscope image of hMSCs cultured for 28 days
in non-osteogenic media. Magnification 100.
Fig. 2 Phase contrast images of hMSCs cultured in osteogenic media for
7 days (A), 14 days (B), 21 days (C) and 28 days (D). Magnification 100.Real time-polymerase chain reaction (RT-PCR)
In this study, the hMSC cells were cultured as outlined previously
and the mRNA expression of collagen type-II was investigated at
days 7, 14, 21 and 28 of culture. RNA was isolated using Tripure
reagent (Roche Diagnostics, UK) according to the manufactur-
er’s instructions. Briefly, cells were lysed for 5 minutes at room
temperature. Chloroform was then added to the cell lysate and
incubated for 15 minutes. For phase separation the sample was
centrifuged at 6000g for 15 minutes at 4 C. For RNA isolation,
RNA was precipitated by adding isopropanol, samples were
mixed by inversion several times and incubated at room
temperature for 10 minutes, samples were then centrifuged at
6000g for 15 minutes at 4 C. The RNA pellet was washed with
75% ethanol and the sample was centrifuged at 6000g for 10
minutes. Following centrifugation and removal of ethanol the
RNA pellet was air-dried for 5–10 minutes and the pellet resus-
pended in RNase free molecular biology grade water (Sigma-
Aldrich, UK). RNAwas quantified by measuring the absorbance
at 260 nm. The concentration of the RNA was evaluated by
A260/A280 ratio (at least 1.9 taken to be pure) using an Implen
Nanospectrophotometer (Implen, Germany).
Following RNA extraction, first strand complementary DNA
(cDNA) was synthesised using the transcriptor first strand
cDNA synthesis kit (Roche Diagnostics, UK) with random
hexamer primers according to the manufacturer’s protocol.
Briefly, the samples were incubated for 10 minutes at 25 C,
followed by 60 minutes at 50 C. To inactivate reverse tran-
scriptase activity the samples were heated to 85 C for 5 minutes.
The cDNA reaction was performed in Thermo OCR Sprint
(Thermo Electron Corporation, UK).
Quantitative real time PCR was carried out using a Roche
Light-Cycler 2.0 (Roche, Mannheim, Germany), using the
following primers: collagen-IIa (Col2A1) forward,
50-TGGTGCTAATGGCGAGAAG-30 and reverse,
50-CCCAGTCTCTCCACGTTCAC-30 (accession number: NM-
001844.4) and GAPDH forward, 50-AGCCACATCGCTCA-
GACAC-30 and reverse 50-GCCCAATACGACCAAATCC-30
(accession number NM-002046.3). hMSC cDNA was denatured
at 95 C for 10 min, and 45 cycles of three-step amplification
(denaturation, 95 C for 10 s; annealing, 60 C for 15 s; and,
elongation 72 C for 10 s). At the end of the cycling, subsequent
melt curve analysis was performed between 60 and 97 C with
a heating rate of 0.1 C s1 in continuous acquisition mode to
check the specificity of amplication and the possible presence of
byproducts. All samples were amplified in triplicate, and the
GAPDH gene was used as the reference to normalise the data
using the Roche software.
Results and discussion
Cell morphology
Both non-osteogenic and osteogenic cell cultures underwent
differing growth patterns, as expected. As can be seen in Fig. 1,
for cells grown in non-osteogenic media, there was no evidence of
mineral formation. Non-osteogenic hMSCs maintained a fibro-
blast-like morphology with a spindle-like shaped cell body
throughout the 28 day culture period. The hMSCs grown in
osteogenic media showed evidence of an opaque white growth on2474 | Analyst, 2011, 136, 2471–2481the fused silica surface, which increased in both density and
thickness over the culture period, however, mineralisation was
not apparent during the first seven days of culture (as shown in
Fig. 2A). From as early as day 7, hMSCs cultured in osteogenic
media exhibited a different morphology. At this point the
hMSCs lost their fibroblast appearance and became cuboidal in
shape (as shown in Fig. 2A). By day 14 there was evidence of
discrete patches of cellular/protein aggregation, and from the
literature it is known that such aggregates occur prior to nodule
formation and mineralisation (as shown in Fig. 2B). hMSCs
cultured in osteogenic media for 21 and 28 days showed the
formation of dense mineralised structures, which are described as
‘‘bone nodules’’ (as shown in Fig. 2C and D).7,8,21 At day 28 there
is also evidence to suggest that there are what is presumed to be
migratory osteoblasts present at the outer regions of the cell
monolayer and it is envisaged that if samples were to remain in
culture in the presence of osteogenic media that new bone
material would be laid down by these cells, although further
work is required for confirmation. Similarly to Gentleman et al.,
the nodules formed from hMSCs occurred in discrete patches
throughout the culture and cellular aggregation was observed
preceding mineralisation.7 Despite this, AR staining of osteo-
genic hMSCs revealed positive staining for calcium deposition
which significantly increased through each 7 day interval (as
shown in Fig. 3A–D). Quantification of AR staining of hMSCsThis journal is ª The Royal Society of Chemistry 2011
Fig. 3 Alizarin red staining of hMSCs cultured in osteogenic media for 7 days (A), 14 days (B), 21 days (C) and 28 days (D). Magnification 100. (E)
Quantification of Alizarin red staining of hMSCs cultured in non-osteogenic and osteogenic media.cultured in non-osteogenic media remains constant from days
0–14, with an increase observed between days 14–21, which is
thought to be due to cell proliferation. The AR staining of
hMSCs cultured in osteogenic media increases with culture time,
with staining increasing rapidly between days 14–21 with day 28
showing the maximum amount of AR staining (as shown in
Fig. 3E). Osteoblasts initiate the calcification process and
produce what is referred to as osteoid. Osteoid is an intracellularThis journal is ª The Royal Society of Chemistry 2011matrix composed of collagen fibrils and fibres combined with
a proteinaceous component. During the process of ossification,
hardening and calcification of the matrix occurs around the
osteoid.27–29 It is therefore suggested that the significant increase
of AR staining between days 14–21 is due to mineralisation and
calcification of the osteoid laid down by osteoblasts.
The standard biological techniques used to assess morphology
and histology provide information that is limited because itAnalyst, 2011, 136, 2471–2481 | 2475
cannot distinguish between nodules, therefore a different
approach was required.
Premineralised hMSCs
The Raman spectra of both non-osteogenic hMSCs and hMSCs
grown in osteogenic media for 7 days (as shown in Fig. 4 and 5A,
respectively) are dominated with protein features, including the
amide I band (1659 cm1), skeletal C–C vibrations (936 cm1)
and amide III vibrations (1284 cm1). Peaks indicative of lipids at
786, 1095, 1575 cm1 and phospholipids at 1065, 1127, 1301 cm1
are observed. C–N–H amide III stretches (1246 and 1269 cm1),
hydroxyproline (950 cm1) and proline (921 cm1) are also
evident. The Raman spectrum of hMSCs grown in non-osteo-
genic media show no evidence of a PO4
3 symmetric stretching
band indicating that although the morphological characteristics
of the cells changed as they became confluent there were no
significant changes observed spectrally.
At day 14 there were no nodules formed in the culture so the
protein/cell aggregates described previously were examined. The
Raman spectrum of hMSCs cultured for 14 days in osteogenic
media shows changes in the intensity of protein bands, however,
the lipid and phospholipid peaks show no distinguishable
differences (as shown in Fig. 5B). The regions in the spectra that
correspond to the proteinaceous matrix of the cell aggregates
reveal a Raman spectrum that can be associated with that of
collagen type-II. A collagen type-II template is produced prior to
bone mineralisation and is a known to be the main component of
cartilage which is produced during endochondral ossification.
Similar findings were observed by Gentleman et al. who after the
analysing the covariance matrix revealed a correlation coefficient
of 0.96 when comparing animal derived MSCs with type-II
collagen.7 In order to further confirm that collagen type-II was
present, immunocytochemical localisation with antibodies to
type-II collagen was performed on hMSCs cultured in osteogenic
media for 14 days (as shown in Fig. 5C and D). Significant
positive staining of collagen type-II was observed in the hMSC
cell/protein aggregates present at day 14. Real-time PCR was
then performed to investigate the expression of the collagen type-
II gene through the 28 day culture and melt curve analysis wasFig. 4 Raman spectra of hMSCs cultured in non-osteogenic media for
28 days.
Fig. 5 Raman spectra of premineralised hMSCs cultured in osteogenic
media at day 7 (A), day 14 (B), day 21 (F), day 28 (G). Immunocyto-
chemical localisation of type-II collagen in hMSCs cultured for 14 days in
(C) non-osteogenic media and (D) osteogenic media. (E) Relative
expression of hMSCs cultured in non-osteogenic media compared with
the expression of hMSCs cultured in osteogenic media for 14 days
determined by quantitative real-time reverse-transcriptase polymerase
chain reaction (RT-PCR) of the type-II collagen (Col2A1) gene. Note
that the y axis is a logarithmic scale.
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Fig. 6 Immunocytochemical localisation of bone specific proteins SPARC, osteocalcin, osteopontin and alkaline phosphatase of hMSCs culture in
non-osteogenic media (A–D) and osteogenic media (E–H) for 28 days.carried out to check the specificity of amplication and the
possible presence of byproducts (not shown here). The gene
expression for collagen type-II indicates a significant up-regula-
tion at day 14 when compared to the day 14 control, as illustrated
in Fig. 5E. The Raman spectrum of hMSCs cultured for 14 days
in osteogenic media shows the inclusion of a PO4
3 symmetric
stretch at approximately 960 cm1 in the spectra, indicating that
although no nodule formation was observed, the cell/protein
aggregates reveal the beginning of mineralisation. This therefore
highlights that the cells have differentiated into osteoblasts,
which have begun to calcify.7Mineralised hMSCs
By days 21 and 28, hMSCs cultured in osteogenic media con-
tained mineralised nodules and the peaks indicative of collagen
type-II were no longer detected in the Raman spectra. For these
samples instead the Raman spectrum revealed bands that are
characteristic of bone tissue and is dominated by the PO4
3
symmetric stretch near 960 cm1 which is associated with
hydroxyapatite Ca10(PO4)6(OH)2. Weaker peaks are also
observed at carbonate (substituted CO3
2 in plane vibrations
1070 cm1) and phosphate (1030–1100 cm1) modes (as shown in
Fig. 5F and G). The de novo bone mineral is deposited on an
ECM of which the main composition is collagen type-I. This can
be observed in the Raman spectra by the inclusion of prominent
protein bands including amide I (1665 cm1), amide III (1245–
1270 cm1) and a CH2 wag (1445 cm
1).7,10,11,21,30,31 Immunocy-
tochemistry was performed to confirm the presence of bone
specific proteins, SPARC, osteocalcin, osteopontin, and alkaline
phosphatase of hMSCs cultured for 28 days in both osteogenic
and non-osteogenic media. Significant positive staining on
osteogenic cultures is observed when compared to the non-
osteogenic control taken at the same time-point, as shown in
Fig. 6A–H.
The Raman spectra of the mineralised nodules observed at
days 21 and 28 have similarities, however, changes in the
mineral environment can be characterised by variations in theThis journal is ª The Royal Society of Chemistry 2011phosphate band shape and frequency. Therefore univariate
peak analysis was carried out to aid in the understanding of
bone formation at different stages of development, as detailed in
Table 2.7,9,24
The carbonate-to-phosphate ratios and mineral-to-matrix
ratios for each of the culture time points were calculated from an
average of three band intensities (as shown in Fig. 7A and
B).7–10,21,24 The carbonate-to-phosphate ratio is a measure of the
inclusion of carbonate into the mineral lattice. Fig. 7A shows the
carbonate-to-phosphate ratios from hMSCs cultured in osteo-
genic media for up to 28 days. The carbonate-to-phosphate ratio
for day 7 is not shown because the carbonate band intensity was
too weak to allow accurate calculations to be performed. The
other culture time points revealed an increase in the carbonate-
to-phosphate ratio and this occurred throughout the culture. It
was observed that the carbonate-to-phosphate ratio was signifi-
cantly higher in hMSCs cultured for 21 days when compared to
those cultured for 14 days, suggesting that carbonate substitution
occurred most rapidly between days 14 and 21. At day 28 the
carbonate-to-phosphate ratio shows an increase from 0.36 to
0.37 indicating that carbonate substitution was significantly
reduced after 21 days in culture. The mineral-to-matrix ratio of
hMSCs cultured for 28 days was significantly higher between all
culture time points and this increased with culture time, with the
largest increase occurring between days 21 and 28. This suggested
that an increased amount of mineral is found in older tissue
(as shown in Fig. 7B). Mineral deposition occurs most rapidly
during days 14 and 28 and as a consequence during this time the
mineral-to-matrix ratio increased quite dramatically. Similarly,
the extent of mineral crystallinity can be calculated from the
FWHM of the PO4
3 band. Results indicate that the crystallinity
of hMSCs cultured for 21 days in osteogenic media is signifi-
cantly higher than the crystallinity observed for those at day 28,
which is illustrated by a lower FWHM.7,9,24 When all univariate
peak analysis are taken together, this data suggests that although
the hMSCs formed dense mineral at day 28, this mineral was of
a lower crystallinity and had a higher degree of carbonate
substitution than at day 21.Analyst, 2011, 136, 2471–2481 | 2477
Table 2 Table detailing the phosphate peak (PO4
3) parameters and mineral properties as determined by univariate analysis carried out by curve fitting
Raman spectra of hMSCs cultured for 7–28 days. n Represents the number of spectra used for each group
Phosphate peak
Frequency/cm1 FWHM/cm1 Mineral-to-matrix ratio Carbonate-to-phosphate ratio
Day 7 (n ¼ 8) — — 0.38  0.52 —
Day 14 (n ¼ 8) 960.72  1.96 75.04  39.51 7.47  4.17 0.19  0.20
Day 21 (n ¼ 8) 958.84  0.93 72.19  4.86 19.14  1.42 0.36  0.86
Day 28 (n ¼ 8) 960.2  1.43 92.2  8.09 35.16  5.95 0.37  0.17Univariate analysis enabled differences in crystallinity to be
monitored. This was determined by resolving changes of the
phosphate band shape and frequency, however, such analysis is
unable to characterise the various mineral environments that are
present in bone. Therefore, multivariate techniques including
PCA and factor analysis were performed on the Raman spectra
of day 28 hMSCs cultured in osteogenic media. The 2D plot
comparing the four different culture time points for the osteo-
genic hMSCs is displayed in Fig. 8A. By focusing first on theFig. 7 (A) Carbonate-to-phosphate ratio (CO3
2, 1070 cm1; PO4
3, 960
cm1) from hMSCs cultured in osteogenic media for 28 days. Day 7 is not
shown because the carbonate band intensity is too weak to allow an
accurate calculation. (B) Mineral-to-matrix ratio (PO4
3, 960 cm1;
Hydroxyproline 850 cm1) from hMSCs cultured in osteogenic media for
28 days. The values shown are averaged carbonate-to-phosphate ratios
and mineral-to-matrix ratios for each time point.
2478 | Analyst, 2011, 136, 2471–2481difference between the four culture times, a clear discrimination
can be seen between all time points as expected from the differ-
ences seen in their Raman spectra. PC1 and PC2 show a clear
difference between the hMSCs at days 21 and day 28 which are
clustered in quite compact groups while the score plot showed
that the hMSCs at days 7 and 14 are considerably more scattered.
PC1 and PC2 account for 54% and 30% of the variance of data,
respectively, however, PC2 is the distinguishing PC that is
responsible for group separation. While there is distinct clus-
tering of the four time points, overlap is still present which is
presumably due to their many functional aspects. It also high-
lights that there are chemical and molecular differences between
the culture times. Overall, PCA shows good separation in theFig. 8 (A) 2D scatter plot using scores of PC1 and PC2 of Raman
spectra of hMSCs cultured in osteogenic media for 7–28 days and (B) plot
of the loadings corresponding to the first three principal components.
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Fig. 9 Factor analysis of mineralised nodules after 14, 21 and 28 days in culture. (A) Matrix factor describing the protein component of mineralised
nodules of hMSCs. Mineral factors produced for day 14 (B), day 21 (C and D) and day 28 (E and F).Raman spectra of hMSCs cultured for 21 and 28 days but no
major separation in the Raman spectra at days 7 and 14 is
observed. The corresponding loading plots, shown in Fig. 8B,
highlight the possible changes which fall around 500–1000 cm1,
and more specifically 960 cm1. With regards to the spectra of
mineralised nodules, the principal components can be added and
subtracted from one another (rotated) resulting in ‘factors’ that
represent the various mineral and matrix components that are
present in a sample. As mentioned previously, both the position
and shape of the PO4
3 band highlight changes in mineralThis journal is ª The Royal Society of Chemistry 2011crystallinity, therefore it is especially important when factor
analysis is used to reveal how various tissue components change
during the culture.7,9
Generally the apatite environments of mineralised tissue can
be classified into three broad mineral categories which contain
three different PO4
3 band frequencies. A disordered amorphous
apatite lattice is represented by a band with a Raman shifted
frequency between 945 and 950 cm1. It is not known if this band
frequency originates from an amorphous calcium phosphate or
from an A-type carbonate substitution where carbonate isAnalyst, 2011, 136, 2471–2481 | 2479
substituted for hydroxide; therefore, the term disordered phos-
phate is used to describe this mineral species. A B-type
carbonate-substituted apatite produces a Raman frequency
between the region of 955 and 959 cm1. Finally, in a crystalline
non-substituted hydroxyapatite, the PO4
3 band frequency is
between 962 and 964 cm1.9,21,32–34 Bone tissue is a complex
material that is composed of various amounts of each of these
three mineral species, and consequently, the resulting PO4
3 band
is a sum of all three bands. The most commonly identified
mineral species in the spectrum of bone tissue is a carbonated
apatite phosphate.9 Hence, in a Raman spectrum the frequency
and position of the phosphate band is in the 955–959 cm1
region. This band is symmetric due to the inclusion of varying
amounts of disordered phosphate and the more crystalline non-
substituted phosphate to the left and right sides of the main
band.7,9 Factor analysis of differentiated hMSC produced one
mineral factor for day 14, and two mineral factors for both days
21 and 28, respectively, (as shown in Fig. 9A–F). At day 21 the
two dominant mineral species factors indicate an amorphous
phosphate species (as shown in Fig. 9C) and a B-type carbonate-
substituted apatite (as shown in Fig. 9D). Similarly factors of day
28 hMSCs yielded a B-type carbonate-substituted apatite
(as shown in Fig. 9E) and a crystalline non-substituted
hydroxyapatite, as shown in Fig. 9F. In contrast, factor analysis
of day 14 produced only one mineral factor: a crystalline non-
substituted hydroxyapatite (Fig. 9B). Gentleman et al. indicated
that the Raman signal of synthetic carbonated hydroxyapatite is
similar to that observed of a crystalline non-substituted apatite
which was observed at day 14.7 This data indicates that the
hMSCs nodules examined at days 21 and 28 contained mineral
species that are similar to what is expected in native bone, namely
a disordered amorphous apatite, a B-type carbonate-substituted
apatite and a crystalline non-substituted hydroxyapatite. In
contrast, day 14 was dominated by one mineral factor which can
be compared to synthetic hydroxyapatite. This time point failed
to exhibit the more complex interaction of mineral species
observed at days 21 and 28.7,9,11,30,31Conclusion
These findings suggest that during the early stages of the osteo-
genic differentiation of hMSCs, a collagen type-II template is
produced before mineralisation occurs, therefore this reflects the
process of endochondral ossification that was described previ-
ously. Briefly, this process is initiated by the hMSCs which
aggregate in areas of bone formation. The cells then develop into
chondrocytes that differentiate and become hypertrophic giving
rise to osteoblasts which lay down bone matrix resulting in the
formation of hydroxyapatite in the matrix. The collagen type-II
observed at early culture did not continue throughout the 28
days, instead the cells created a protein dominated ECM that
mineralised over culture time. The hMSC nodules at days 21 and
28 each contain two mineral species, that are similar to those
observed in native bone. Due to the different mineral factors at
days 21 and 28 it is suggested that similar to native bone, the
remodeling is continuous throughout the culture and is reflected
in a combination of older and newer bone being present. Both the
carbonate-to-phosphate ratio and the mineral-to-matrix ratio
increased with culture times which further suggests that the2480 | Analyst, 2011, 136, 2471–2481various mineral species observed can be compared to native
bone. Day 14 hMSC aggregates failed to produce combinations
of multiple mineral species and had a significantly lower
carbonate-to-phosphate ratio than bone nodules formed at days
21 and 28 of culture. This suggests that although hMSCs at day
14 produced less mineral, the mineral that was detected can be
related to the crystalline, non-substituted mineral found in
synthetic hydroxyapatite.
One vital issue when considering the transfer of regenerative
medicine into the clinical setting is the ability to determine the
success of such products to replicate the functionality of their
tissue of origin. Here mesenchymal stem cells were obtained from
a healthy human donor and were directed towards an osteogenic
lineage, samples were taken at seven day intervals from days 7
through to day 28. Differences were observed between hMSCs at
early culture and at late culture. hMSCs at days 21 and 28 formed
a bone material that had many similarities to that of native bone,
namely, increasing carbonate-to-phosphate and mineral-to-
matrix ratios and various mineral species. In contrast, hMSCs at
day 14 showed various differences with regards to the composi-
tion and development. These findings could potentially have
a significant impact on the assessment of bone quality and were
only possible when combining both biological and material-
based techniques, namely Raman spectroscopy.Acknowledgements
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